Sugammadex: Applications in Pediatric Critical Care

Abstract

Sugammadex is a novel pharmacologic agent, which reverses neuromuscular blockade with a mechanism that differs from acetylcholinesterase inhibitors such as neostigmine. There is a growing body of literature demonstrating its efficacy in pediatric patients of all ages. Prospective trials have demonstrated a more rapid and more complete reversal of rocuronium-induced neuromuscular blockade than the acetylcholinesterase inhibitor, neostigmine. Unlike the acetylcholinesterase inhibitors, sugammadex effectively reverses intense or complete neuromuscular blockade. It may also be effective in situations where reversal of neuromuscular blockade is problematic including patients with neuromyopathic conditions or when acetylcholinesterase inhibitors are contraindicated. This article reviews the physiology of neuromuscular transmission as well as the published literature, regarding the use of sugammadex in pediatric population including the pediatric intensive care unit population. Clinical applications are reviewed, adverse effects are discussed, and dosing algorithms are presented.

Keywords

neuromuscular blockade - sugammadex - train-of-four monitoring - neostigmine

• References

• 1 Sharpe MD. The use of muscle relaxants in the intensive care unit. Can J Anaesth 1992; 39 (09) 949-962
• 2 Adelson PD, Bratton SL, Carney NA. , et al; American Association for the Surgery of Trauma; Child Neurology Society; International Society for Pediatric Neurosurgery; International Trauma Anesthesia and Critical Care Society; Society of Critical Care Medicine; World Federation of Pediatric Intensive and Critical Care Societies. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents. Chapter 9. Use of sedation and neuromuscular blockade in the treatment of severe pediatric traumatic brain injury. Pediatr Crit Care Med 2003; 4 (3, Suppl): S34-S37
• 3 Rhoney DH, Murry KR. National survey on the use of sedatives and neuromuscular blocking agents in the pediatric intensive care unit. Pediatr Crit Care Med 2002; 3 (02) 129-133
• 4 Greenberg SB, Vender J. The use of neuromuscular blocking agents in the ICU: where are we now?. Crit Care Med 2013; 41 (05) 1332-1344
• 5 Chamorro C, Borrallo JM, Romera MA, Silva JA, Balandín B. Anesthesia and analgesia protocol during therapeutic hypothermia after cardiac arrest: a systematic review. Anesth Analg 2010; 110 (05) 1328-1335
• 6 Heidemann SM, Nair A, Bulut Y, Sapru A. Pathophysiology and management of acute respiratory distress syndrome in children. Pediatr Clin North Am 2017; 64 (05) 1017-1037
• 7 de Souza CM, Romero FE, Tardelli MA. Assessment of neuromuscular blockade in children at the time of block reversal and the removal of the endotracheal tube. Rev Bras Anestesiol 2011; 61 (02) 145-149 , 150–155, 78–83
• 8 Meretoja OA. Neuromuscular block and current treatment strategies for its reversal in children. Paediatr Anaesth 2010; 20 (07) 591-604
• 9 Bom A, Hope F, Rutherford S, Thomson K. Preclinical pharmacology of sugammadex. J Crit Care 2009; 24 (01) 29-35
• 10 Hunter JM, Flockton EA. The doughnut and the hole: a new pharmacological concept for anaesthetists. Br J Anaesth 2006; 97 (02) 123-126
• 11 Cammu G, De Kam PJ, Demeyer I. , et al. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers. Br J Anaesth 2008; 100 (03) 373-379
• 12 Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005; 103 (04) 695-703
• 13 Sorgenfrei IF, Norrild K, Larsen PB. , et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology 2006; 104 (04) 667-674
• 14 Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg 2007; 104 (03) 575-581
• 15 Chambers D, Paulden M, Paton F. , et al. Sugammadex for reversal of neuromuscular block after rapid sequence intubation: a systematic review and economic assessment. Br J Anaesth 2010; 105 (05) 568-575
• 16 Murray MJ, DeBlock H, Erstad B. , et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2016; 44 (11) 2079-2103
• 17 Thilen SR, Bhananker SM. Qualitative neuromuscular monitoring: how to optimize the use of a peripheral nerve stimulator to reduce the risk of residual neuromuscular blockade. Curr Anesthesiol Rep 2016; 6: 164-169
• 18 Naguib M, Brull SJ, Kopman AF. , et al. Consensus statement on perioperative use of neuromuscular monitoring. Anesth Analg 2018; 127 (01) 71-80
• 19 Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 107 (01) 130-137
• 20 Shorten GD. Postoperative residual curarisation: incidence, aetiology and associated morbidity. Anaesth Intensive Care 1993; 21 (06) 782-789
• 21 Eriksson LI. The effects of residual neuromuscular blockade and volatile anesthetics on the control of ventilation. Anesth Analg 1999; 89 (01) 243-251
• 22 Vested M, Tarpgaard M, Eriksen K, Rasmussen LS. Incidence of residual neuromuscular blockade in children below 3 years after a single bolus of cisatracurium 0.1 mg/kg: a quality assurance study. Acta Anaesthesiol Scand 2020; 64 (02) 168-172
• 23 Klucka J, Kosinova M, Krikava I, Stoudek R, Toukalkova M, Stourac P. Residual neuromuscular block in paediatric anaesthesia. Br J Anaesth 2019; 122 (01) e1-e2
• 24 Lee C, Jahr JS, Candiotti KA, Warriner B, Zornow MH, Naguib M. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine. Anesthesiology 2009; 110 (05) 1020-1025
• 25 Barbosa FT, da Cunha RM. Reversal of profound neuromuscular blockade with sugammadex after failure of rapid sequence endotracheal intubation: a case report. Rev Bras Anestesiol 2012; 62 (02) 281-284
• 26 Plaud B, Meretoja O, Hofmockel R. , et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology 2009; 110 (02) 284-294
• 27 Ghoneim AA, El Beltagy MA. Comparative study between sugammadex and neostigmine in neurosurgical anesthesia in pediatric patients. Saudi J Anaesth 2015; 9 (03) 247-252
• 28 Ozgün C, Cakan T, Baltacı B, Başar H. Comparison of reversal and adverse effects of sugammadex and combination of - anticholinergic-anticholinesterase agents in pediatric patients. J Res Med Sci 2014; 19 (08) 762-768
• 29 Kara T, Ozbagriacik O, Turk HS. , et al. Sugammadex versus neostigmine in pediatric patients: a prospective randomized study[in Portuguese]. Rev Bras Anestesiol 2014; 64 (06) 400-405
• 30 El Sayed M, Hassan S. Does sugammadex facilitate recovery after outpatient tonsillectomy in children?. Egypt J Anaesth 2016; 32: 447-450
• 31 Güzelce D, Kendigelen P, Tütüncü AÇ, Kaya G, Altıntaş F. Comparison of sugammadex and neostigmine in terms of time to extubation in pediatrics. Med Bull Haseki 2016; 54: 207-211
• 32 Matinyan NV, Saltanov AI, Mareeva AA. [Sugammadex use experience in pediatric oncology]. Anesteziol Reanimatol 2013; 8 (01) 34-37
• 33 Martin DP, Crawford J, Uffman J, Michler R, Tobias JD. Sugammadex and fast-track anesthesia for pediatric cardiac surgery in a developing country. Anaesth Pain Intensive Care 2016; 20: S17-S22
• 34 Gaver RS, Brenn BR, Gartley A, Donahue BS. Retrospective analysis of the safety and efficacy of sugammadex versus neostigmine for the reversal of neuromuscular blockade in children. Anesth Analg 2019; 129 (04) 1124-1129
• 35 Franz AM, Chiem J, Martin LD, Rampersad S, Phillips J, Grigg EB. Case series of 331 cases of sugammadex compared to neostigmine in patients under 2 years of age. Paediatr Anaesth 2019; 29 (06) 591-596
• 36 Erbabacan E, Köksal GM, Şeker TB, Ekici B, Özcan R, Altindaş F. Anaesthesia management and use of sugammadex in a patient with Ullrich's disease. Turk J Anaesthesiol Reanim 2015; 43 (05) 356-359
• 37 Shimauchi T, Yamaura K, Sugibe S, Hoka S. Usefulness of sugammadex in a patient with Becker muscular dystrophy and dilated cardiomyopathy. Acta Anaesthesiol Taiwan 2014; 52 (03) 146-148
• 38 Stewart PA, Phillips S, De Boer HD. Sugammadex reversal of rocuronium-induced neuromuscular blockade in two types of neuromuscular disorders: Myotonic dystrophy and spinal muscular atrophy. Rev Esp Anestesiol Reanim 2013; 60 (04) 226-229
• 39 de Boer HD, van Esmond J, Booij LH, Driessen JJ. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy. Paediatr Anaesth 2009; 19 (12) 1226-1228
• 40 Takeda A, Kawamura M, Hamaya I, Kitamura H, Muto R, Mitono H. [Case of anesthesia for thoracoscopic thymectomy in a pediatric patient with myasthenia gravis: reversal of rocuronium-induced neuromuscular blockade with sugammadex]. Masui 2012; 61 (08) 855-858
• 41 Vymazal T, Krecmerova M, Bicek V, Lischke R. Feasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery - a series of 117 cases. Ther Clin Risk Manag 2015; 11: 1593-1596
• 42 Pickard A, Lobo C, Stoddart PA. The effect of rocuronium and sugammadex on neuromuscular blockade in a child with congenital myotonic dystrophy type 1. Paediatr Anaesth 2013; 23 (09) 871-873
• 43 Witte W, Nobel C, Hilpert J. Anesthesia and Angelman syndrome [in German]. Anaesthesist 2011; 60 (07) 633-640
• 44 Baumgartner P. Rocuronium and sugammadex in myotonic dystrophy. Anaesth Intensive Care 2010; 38 (05) 959-960
• 45 Backman SB, Bachoo M, Polosa C. Mechanism of the bradycardia produced in the cat by the anticholinesterase neostigmine. J Pharmacol Exp Ther 1993; 265 (01) 194-200
• 46 Samuels SI, Kanter SF. Anaesthesia for major surgery in a patient with a transplanted heart. Br J Anaesth 1977; 49 (03) 265-267
• 47 Gómez-Ríos MÁ. Anaesthesia for non-cardiac surgery in a cardiac transplant recipient. Indian J Anaesth 2012; 56 (01) 88-89
• 48 Backman SB, Ralley FE, Fox GS. Neostigmine produces bradycardia in a heart transplant patient. Anesthesiology 1993; 78 (04) 777-779
• 49 Backman SB, Fox GS, Stein RD, Ralley FE. Neostigmine decreases heart rate in heart transplant patients. Can J Anaesth 1996; 43 (04) 373-378
• 50 Beebe DS, Shumway SJ, Maddock R. Sinus arrest after intravenous neostigmine in two heart transplant recipients. Anesth Analg 1994; 78 (04) 779-782
• 51 Gómez-Ríos MÁ, López LR. Use of combination of rocuronium and sugammadex in heart transplant recipients. Anaesth Intensive Care 2012; 40 (05) 903-904
• 52 Tezcan B, Şaylan A, Bölükbaşı D, Koçulu R, Karadeniz Ü. Use of sugammadex in a heart transplant recipient: review of the unique physiology of the transplanted heart. J Cardiothorac Vasc Anesth 2016; 30 (02) 462-465
• 53 Miller K, Hall B, Tobias JD. Sugammadex to reverse neuromuscular blockade in a child with a past history of cardiac transplantation. Ann Card Anaesth 2017; 20 (03) 376-378
• 54 King A, Naguib A, Tobias JD. Bradycardia in a pediatric heart transplant recipient: is it the sugammadex?. J Pediatr Pharmacol Ther 2017; 22 (05) 378-381
• 55 Peeters P, Passier P, Smeets J. , et al. Sugammadex is cleared rapidly and primarily unchanged via renal excretion. Biopharm Drug Dispos 2011; 32 (03) 159-167
• 56 Sparr HJ, Vermeyen KM, Beaufort AM. , et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology 2007; 106 (05) 935-943
• 57 Cammu G, Van Vlem B, van den Heuvel M. , et al. Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment. Br J Anaesth 2012; 109 (03) 382-390
• 58 Carlos RV, Torres ML, de Boer HD. The use of rocuronium and sugammadex in paediatric renal transplantation: two case reports. Eur J Anaesthesiol 2016; 33 (05) 383-386
• 59 Staals LM, Snoeck MM, Driessen JJ, Flockton EA, Heeringa M, Hunter JM. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function. Br J Anaesth 2008; 101 (04) 492-497
• 60 Staals LM, Snoeck MM, Driessen JJ. , et al. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. Br J Anaesth 2010; 104 (01) 31-39
• 61 Panhuizen IF, Gold SJ, Buerkle C. , et al. Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment. Br J Anaesth 2015; 114 (05) 777-784
• 62 Adams DR, Tollinche LE, Yeoh CB. , et al. Short-term safety and effectiveness of sugammadex for surgical patients with end-stage renal disease: a two-centre retrospective study. Anaesthesia 2020; 75 (03) 348-352
• 63 Bom A, Bradley M, Cameron K. , et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002; 41 (02) 266-270
• 64 Carlos RV, Torres ML, de Boer HD. Rocuronium and sugammadex in a 3 days old neonate for draining an ovarian cyst. Neuromuscular management and review of the literature. Braz J Anesthesiol 2016; 66 (04) 430-432
• 65 Cardenas VHG, Gonzalez FDM. Sugammadex in the neonatal patient. Rev Colomb Anesthesiol 2013; 41: 171-174
• 66 Alonso A, de Boer HD, Booij L. Reversal of rocuronium-induced neuromuscular block by sugammadex in neonates (Abstract). Eur J Anaesthesiol 2014; 31 (Suppl. 52) 163-165
• 67 Krishna SG, Bryant JF, Tobias JD. Management of the difficult airway in the pediatric patient. J Pediatr Intensive Care 2018; 7 (03) 115-125
• 68 Wołoszczuk-Gębicka B, Zawadzka-Głos L, Lenarczyk J, Sitkowska BD, Rzewnicka I. Two cases of the “cannot ventilate, cannot intubate” scenario in children in view of recent recommendations. Anaesthesiol Intensive Ther 2014; 46 (02) 88-91
• 69 Wakimoto M, Burrier C, Tobias JD. Sugammadex for rapid intraoperative reversal of neuromuscular blockade in a neonate. J Med Cases 2018; 9: 400-402
• 70 Naguib M, Brewer L, LaPierre C, Kopman AF, Johnson KB. The myth of rescue reversal in “can't intubate, can't ventilate” scenarios. Anesth Analg 2016; 123 (01) 82-92
• 71 Apfelbaum JL, Hagberg CA, Caplan RA. , et al; American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Practice guidelines for management of the difficult airway: an updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology 2013; 118 (02) 251-270
• 72 Black AE, Flynn PE, Smith HL, Thomas ML, Wilkinson KA. ; Association of Pediatric Anaesthetists of Great Britain and Ireland. Development of a guideline for the management of the unanticipated difficult airway in pediatric practice. Paediatr Anaesth 2015; 25 (04) 346-362
• 73 Langley RJ, McFadzean J, McCormack J. The presumed central nervous system effects of rocuronium in a neonate and its reversal with sugammadex. Paediatr Anaesth 2016; 26 (01) 109-111
• 74 Hashimoto M, Sato Boku A, Tachi N. , et al. Two cases of rocuronium-induced anaphylaxis/anaphylactic shock successfully treated with sugammadex. Anesth Prog 2019; 66 (03) 151-155
• 75 De La Cruz I, Errando C, Calaforra S. Treatment of anaphylaxis to rocuronium with sugammadex: a case report with bronchospasm as the only symptom. Turk J Anaesthesiol Reanim 2019; 47 (01) 69-72
• 76 Rahe-Meyer N, Fennema H, Schulman S. , et al. Effect of reversal of neuromuscular blockade with sugammadex versus usual care on bleeding risk in a randomized study of surgical patients. Anesthesiology 2014; 121 (05) 969-977
• 77 Bilgi M, Demirhan A, Akkaya A, Tekelioglu UY, Kocoglu H. Sugammadex associated persistent bradycardia. Int J Med Sci Public Health 2014; 3: 372-374
• 78 Bhavani SS. Severe bradycardia and asystole after sugammadex. Br J Anaesth 2018; 121 (01) 95-96
• 79 Osaka Y, Shimada N, Satou M. , et al. A case of atrioventricular block (Wenckebach type) induced by sugammadex. J Anesth 2012; 26 (04) 627-628
• 80 Carron M, Zarantonello F, Tellaroli P, Ori C. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials. J Clin Anesth 2016; 35: 1-12
• 81 Koyuncu O, Turhanoglu S, Ozbakis Akkurt C. , et al. Comparison of sugammadex and conventional reversal on postoperative nausea and vomiting: a randomized, blinded trial. J Clin Anesth 2015; 27 (01) 51-56
• 82 Hristovska AM, Duch P, Allingstrup M, Afshari A. The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis. Anaesthesia 2018; 73 (05) 631-641
• 83 Alsuhebani M, Sims T, Hansen JK. , et al. Heart rate changes following the administration of sugammadex in children: a prospective, observational study. J Anesth 2020 ; in press
• 84 Takazawa T, Mitsuhata H, Mertes PM. Sugammadex and rocuronium-induced anaphylaxis. J Anesth 2016; 30 (02) 290-297
• 85 Jeyadoss J, Kuruppu P, Nanjappa N, Van Wijk R. Sugammadex hypersensitivity-a case of anaphylaxis. Anaesth Intensive Care 2014; 42 (01) 89-92
• 86 Godai K, Hasegawa-Moriyama M, Kuniyoshi T. , et al. Three cases of suspected sugammadex-induced hypersensitivity reactions. Br J Anaesth 2012; 109 (02) 216-218
• 87 Baronos S, Selvaraj BJ, Liang M, Ahmed K, Yarmush J. Sugammadex-induced bronchospasm during desflurane anaesthesia. Br J Anaesth 2019; 123 (01) e155-e156
• 88 Tsur A, Kalansky A. Hypersensitivity associated with sugammadex administration: a systematic review. Anaesthesia 2014; 69 (11) 1251-1257
• 89 Miyazaki Y, Sunaga H, Kida K. , et al. Incidence of anaphylaxis associated with sugammadex. Anesth Analg 2018; 126 (05) 1505-1508
• 90 Min KC, Woo T, Assaid C. , et al. Incidence of hypersensitivity and anaphylaxis with sugammadex. J Clin Anesth 2018; 47: 67-73
• 91 Tadokoro F, Morita K, Michihata N, Fushimi K, Yasunaga H. Association between sugammadex and anaphylaxis in pediatric patients: a nested case-control study using a national inpatient database. Paediatr Anaesth 2018; 28 (07) 654-659
• 92 Harper NJN, Cook TM, Garcez T. , et al. Anaesthesia, surgery, and life-threatening allergic reactions: management and outcomes in the 6th National Audit Project (NAP6). Br J Anaesth 2018; 121 (01) 172-188
• 93 Harper NJN, Cook TM, Garcez T. , et al. Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6). Br J Anaesth 2018; 121 (01) 159-171
• 94 Iwasaki H, Takahoko K, Otomo S, Sasakawa T, Kunisawa T, Iwasaki H. A temporary decrease in twitch response following reversal of rocuronium-induced neuromuscular block with a small dose of sugammadex in a pediatric patient. J Anesth 2014; 28 (02) 288-290
• 95 Carollo DS, White WM. Postoperative recurarization in a pediatric patient after sugammadex reversal of rocuronium-induced neuromuscular blockade: a case report. A A Pract 2019 ; in press
• 96 Shimizu T, Toda Y, Shimizu K. , et al. [Increase in serum vecuronium concentration following sugammadex administration in a pediatric patient after prolonged sedation]. Masui 2013; 62 (10) 1225-1229
• 97 Le Corre F, Nejmeddine S, Fatahine C, Tayar C, Marty J, Plaud B. Recurarization after sugammadex reversal in an obese patient. Can J Anaesth 2011; 58 (10) 944-947
• 98 Williams R, Bryant H. Sugammadex advice for women of childbearing age. Anaesthesia 2018; 73 (01) 133-134
• 99 Corda DM, Robards CB. Sugammadex and oral contraceptives: is it time for a revision of the anesthesia informed consent?. Anesth Analg 2018; 126 (02) 730-731
• 100 de Boer HD, Driessen JJ, van Egmond J, Booij LH. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex. Can J Anaesth 2008; 55 (02) 124-125 , author reply 125–126
• 101 Asakura C, Iwasaki H. The use of succinylcholine after sugammadex reversal. J Anesth 2016; 30 (05) 915
• 102 Nishi M, Fujii S, Nitta S. [A two-year-old patient who received readministration of rocuronium for re-operation 30 minutes after sugammadex reversal]. Masui 2011; 60 (10) 1189-1191